{"id":"https://openalex.org/W2109494332","doi":null,"title":"Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.","display_name":"Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.","publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W2109494332","mag":"2109494332","pmid":"https://pubmed.ncbi.nlm.nih.gov/7684320"},"language":"en","primary_location":{"id":"pmid:7684320","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7684320","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078484599","display_name":"Stacey L. Berg","orcid":"https://orcid.org/0000-0003-2832-9994","observed_orcids":["https://orcid.org/0000-0003-2832-9994"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S L Berg","raw_affiliation_strings":["Pediatric Branch, National Cancer Institute, Bethesda, Maryland 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Branch, National Cancer Institute, Bethesda, Maryland 20892","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112487568","display_name":"Diane M. F. Savarese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D M Savarese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024249524","display_name":"Frank M. Balis","orcid":"https://orcid.org/0000-0002-8117-6926","observed_orcids":["https://orcid.org/0000-0002-8117-6926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F M Balis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029672774","display_name":"Andrea M. Denicoff","orcid":"https://orcid.org/0000-0002-9186-8694","observed_orcids":["https://orcid.org/0000-0002-9186-8694"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A M Denicoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010143714","display_name":"M Hillig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Hillig","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J A O'Shaughnessy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111496887","display_name":"DG Poplack","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D G Poplack","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111997075","display_name":"Kenneth H. Cowan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K H Cowan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3861,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.56267557,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"53","issue":"11","first_page":"2587","last_page":"90"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6704000234603882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6704000234603882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.07029999792575836,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.06520000100135803,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.859000027179718},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8939999938011169},{"id":"https://openalex.org/keywords/anthrapyrazoles","display_name":"anthrapyrazoles","score":0.8939999938011169},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.824999988079071},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8840000033378601},{"id":"https://openalex.org/keywords/plasma-elimination","display_name":"plasma elimination","score":0.4650000035762787},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.6949999928474426},{"id":"https://openalex.org/keywords/limited-sampling-strategy","display_name":"limited sampling strategy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/drug-metabolites","display_name":"drug metabolites","score":0.6769999861717224},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6589999794960022},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.6420000195503235},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.9160133600234985},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6960034966468811},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5829249024391174},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.46920672059059143},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44306686520576477},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43895241618156433},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.4313111901283264},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42818740010261536},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42418813705444336},{"id":"https://openalex.org/C2777983669","wikidata":"https://www.wikidata.org/wiki/Q223143","display_name":"Granulocyte","level":2,"score":0.4159401059150696},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2636699378490448},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25580525398254395}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:7684320","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7684320","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Clinical Trial"},{"id":"mag:2109494332","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7684320","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1495968330","https://openalex.org/W1900745022","https://openalex.org/W2037156603","https://openalex.org/W2080422533","https://openalex.org/W2137594651","https://openalex.org/W2411242899"],"related_works":["https://openalex.org/W1495968330","https://openalex.org/W2092701989","https://openalex.org/W2135168578","https://openalex.org/W1875884946","https://openalex.org/W2327200736","https://openalex.org/W2041299107","https://openalex.org/W2315967628","https://openalex.org/W2329391881","https://openalex.org/W2053529558","https://openalex.org/W2077367806"],"abstract_inverted_index":{"Piroxantrone":[0],"is":[1],"an":[2],"anthrapyrazole":[3],"derivative":[4],"with":[5,39,76,165],"broad":[6],"antitumor":[7,181],"activity":[8],"in":[9,37,154,161,189],"vitro.":[10],"In":[11,45],"previous":[12],"phase":[13,26],"I":[14,27],"trials,":[15],"the":[16,50,53,114,122,127,138,141,180,186,197],"dose-limiting":[17],"toxicity":[18],"of":[19,31,35,52,64,72,83,95,116,140,146,169,183],"this":[20,46,170],"agent":[21],"was":[22,43,74,101,110,156,194],"myelosuppression.":[23],"Therefore,":[24],"a":[25,32,61,77,89,147],"and":[28,88,134],"pharmacokinetic":[29,54,144],"study":[30],"1-h":[33],"infusion":[34],"piroxantrone":[36,73,129,149,184,192],"combination":[38],"granulocyte-colony":[40],"stimulating":[41],"factor":[42],"conducted.":[44],"article,":[47],"we":[48,172],"report":[49],"results":[51],"analysis.":[55],"Thirty-seven":[56],"patients":[57],"were":[58],"studied":[59],"over":[60,196],"dosage":[62],"range":[63,201],"150":[65],"to":[66,112,179],"555":[67],"mg/m2.":[68],"The":[69,143],"plasma":[70,123,128,155],"elimination":[71,193],"biexponential":[75],"mean":[78,90],"(+/-":[79,91],"SD)":[80,92],"t1/2":[81,93],"alpha":[82],"3.2":[84],"+/-":[85,97,103],"2.7":[86],"min":[87,136],"beta":[94],"82":[96],"92":[98],"min.":[99],"Clearance":[100],"840":[102],"230":[104],"ml/min/m2.":[105],"A":[106],"limited":[107],"sampling":[108],"strategy":[109],"developed":[111],"allow":[113],"estimation":[115],"total":[117],"drug":[118,211],"exposure":[119,212],"(area":[120],"under":[121],"concentration-time":[124],"curve)":[125],"from":[126],"concentrations":[130,187],"at":[131,185],"30,":[132],"60,":[133],"120":[135],"after":[137],"start":[139],"infusion.":[142],"behavior":[145],"presumed":[148],"metabolite":[150],"not":[151,174],"previously":[152],"described":[153],"also":[157],"characterized.":[158],"Based":[159],"on":[160],"vitro":[162],"cytotoxicity":[163],"studies":[164],"partially":[166],"purified":[167],"extract":[168],"compound,":[171],"do":[173],"believe":[175],"that":[176,204],"it":[177],"contributes":[178],"effects":[182],"observed":[188],"plasma.":[190],"Finally,":[191],"linear":[195],"nearly":[198],"4-fold":[199],"dose":[200,206],"studied,":[202],"indicating":[203],"when":[205],"adjustments":[207],"are":[208],"made,":[209],"systemic":[210],"will":[213],"remain":[214],"predictable.":[215]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}